Search clinical trials for: EFG816
Total 19 results
-
Novartis PharmaceuticalsTerminatedNeovascular Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Geographic AtrophyUnited States
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria PNHLithuania, Japan, Czechia
-
Novartis PharmaceuticalsTerminatedTransplant Associated Microangiopathy TAMFrance, United States, Germany
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Novartis PharmaceuticalsCompleted
-
Alcon ResearchNovartis Institutes for BioMedical ResearchCompleted
-
Novartis PharmaceuticalsCompletedExudative Macular Degeneration | Neovascular Age-elated Macular Degeneration (Wet AMD)United States
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaNetherlands, Korea, Republic of, Spain, Taiwan, Japan, Italy, Canada, United States, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious PanuveitisUnited States, United Kingdom
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Novartis PharmaceuticalsWithdrawn
-
University of CologneCompletedBronchial NeoplasmsSpain, Germany
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Massachusetts General HospitalNovartisActive, not recruitingLung CancerUnited States
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada